AngioDynamics, Inc.
ANGONASDAQHealthcare● Active
$12.03
+$0.09(+0.71%)
Market Cap$496859773
P/E Ratio—
52W High$13.99
52W Low$8.36
AngioDynamics, Inc. (ANGO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ANGO · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-05 | 2024-05 | 2023-05 | 2022-05 | 2021-05 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.29B | $0.30B | $0.34B | $0.32B | $0.29B |
| Cost of Revenue | $0.13B | $0.15B | $0.16B | $0.15B | $0.13B |
| Gross Profit | $0.16B | $0.15B | $0.17B | $0.17B | $0.16B |
| Gross Margin %(computed) | 53.92% | 50.90% | 51.44% | 52.41% | 53.88% |
| Operating Expenses | |||||
| R&D Expenses | $0.03B | $0.03B | $0.03B | $0.03B | $0.04B |
| G&A Expenses | $0.04B | $0.04B | $0.04B | $0.04B | $0.04B |
| Total Operating Expenses | $0.20B | $0.35B | $0.23B | $0.19B | $0.19B |
| Operating Income | ($0.04B) | ($0.19B) | ($0.05B) | ($0.03B) | ($0.04B) |
| Operating Margin %(computed) | -13.66% | -63.32% | -15.11% | -9.00% | -12.12% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.03B) | ($0.19B) | ($0.05B) | ($0.03B) | ($0.04B) |
| Income Tax Expense | ($0.00B) | ($0.01B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Income | ($0.03B) | ($0.18B) | ($0.05B) | ($0.03B) | ($0.03B) |
| Net Margin %(computed) | -11.62% | -60.66% | -15.48% | -8.40% | -10.84% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.83 | $-4.59 | $-1.33 | $-0.68 | $-0.82 |
| Wtd Avg Shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B |
| EBITDA | $0.00B | ($0.01B) | $0.01B | $0.01B | ($0.01B) |
| EBITDA Margin %(computed) | 0.59% | -2.02% | 3.60% | 3.52% | -3.19% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more AngioDynamics, Inc. data
About AngioDynamics, Inc. (ANGO) Income Statement
AngioDynamics, Inc. (ANGO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ANGO reported revenue of $0.29B, gross profit of $0.16B (gross margin 53.92%), and net income of ($0.03B) — a net profit margin of -11.62%.
Frequently asked questions
ANGO · 4 questionsAngioDynamics, Inc. (ANGO) reported revenue of $0.29B for 2025, down 3.8% year-over-year.
ANGO revenueANGO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08